Concepedia

Jianan Gong

JG

Statistics

Publications

28

Citations

3.2K

H-Index

20

Active since

2011

Affiliations

The University of Melbourne(Current)

Walter and Eliza Hall Institute of Medical Research

Chinese Academy of Medical Sciences & Peking Union Medical College

The Royal Melbourne Hospital

Monash University

Jianan Gong is an author at The University of Melbourne specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2011–2025

28

Publications

28

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1.1K citations

, , +11

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Piers Blombery, Mary Ann Anderson, Jianan Gong et al. · Cancer Discovery · 2018 · 426 citations · Full text

, , +10

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Sean Caenepeel, Sean P. Brown, Brian Belmontes et al. · Cancer Discovery · 2018 · 419 citations · Full text

, , +14

Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

Richard W. Birkinshaw, Jianan Gong, Cindy S. Luo et al. · Nature Communications · 2019 · 244 citations · Full text

, , +15

MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia

Xiaoshuang Wang, Jianan Gong, Jia Yu et al. · Blood · 2012 · 167 citations · Full text

, , +14

1–5 of 28